Literature DB >> 11790994

Pregnancy in vasculitis.

Carol A Langford1, Gail S Kerr.   

Abstract

Little is known about pregnancy in patients with vasculitis because of the nature of these diseases and the potential for infertility to occur from effective treatments. However, with the expanding armamentarium of therapeutic options that do not affect reproductive function, it is anticipated that more vasculitis patients will entertain the possibility of conception and consider the outcomes of pregnancy. Relevant issues include the effects of the vasculitis on pregnancy, the effects of the pregnancy on vasculitic disease activity, and the impact of medications used during the peripartum period. Although available data are limited and fall short in many regards, there is support for successful outcomes of pregnancy when conception occurs in disease remission. Maternal and fetal outcome is optimized by the establishment of a multidisciplinary team that can provide preconception evaluation and counseling followed by frequent monitoring throughout the pregnancy and the postpartum period.

Entities:  

Mesh:

Year:  2002        PMID: 11790994     DOI: 10.1097/00002281-200201000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  3 in total

1.  Severe relapse of Wegener's granulomatosis during the early postpartum period.

Authors:  A Woywodt; K de Groot; S Bahte; A Schwarz; H Haller; M Haubitz
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

Review 2.  Postpartum Churg-Strauss syndrome with severe cardiac involvement: description of a case and review of the literature.

Authors:  Domenico Corradi; Roberta Maestri; Fabio Facchetti
Journal:  Clin Rheumatol       Date:  2009-02-24       Impact factor: 2.980

Review 3.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.